{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:34:39Z","timestamp":1791110079918,"version":"4.1.0"},"reference-count":87,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1517\/14656566.3.8.1101","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T21:27:57Z","timestamp":1115242077000},"page":"1101-1108","source":"Crossref","is-referenced-by-count":31,"title":["Treatment of visceral leishmaniasis: a review of current treatment practices"],"prefix":"10.1517","volume":"3","author":[{"given":"Eric","family":"Rosenthal","sequence":"first","affiliation":[{"name":"Service d\u2019H\u00e9matologie Clinique, Centre Hospitalier Universitaire de Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marty","sequence":"additional","affiliation":[{"name":"Groupe de Recherche en Immunopathologie de la Leishmaniose (GRIPL), Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Nice-Sophia-Antipolis et Service de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Nice, H\u00f4pital de l'Archet, BP 3079 06202 Nice C\u00e9dex 3, France, Tel :+33 492 036 254; Fax : + 33 492 036 258;, E-mail : marty@unice.fr"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2005,2,25]]},"reference":[{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(01)90223-8"},{"key":"e_1_2_1_4_1","unstructured":"\u2022Excellent update on the epidemiological problems of leishmaniasis worldwide."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/25.4.862"},{"key":"e_1_2_1_6_1","unstructured":"WORLD HEALTH ORGANISATION: Leishmania\/HIV co-infection South-western Europe 1990\u20131998. World Health Organization Geneva Switzerland. Mimeographed document (2000) WHO\/LEISH\/2000.42."},{"key":"e_1_2_1_7_1","unstructured":"WORLD HEALTH ORGANISATION:Report of the consultative meeting on Leishmania\/HIV coinfection Rome 6\u20137 September 1995. World Health Organization Geneva Switzerland. Mimeographed document (1995) WHO\/LEISH\/95.35\/1995."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90476-X"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-4758(99)01431-3"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1086\/318135"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200106150-00017"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2001.00795.x"},{"key":"e_1_2_1_13_1","unstructured":"\u2022Excellent reflection on this subject."},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1992.46.296"},{"key":"e_1_2_1_15_1","unstructured":"\u2022Good review on the management of leishmaniasis with sodium stibogluconate."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/10.3.560"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1086\/318121"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78612-8"},{"key":"e_1_2_1_19_1","first-page":"562","article-title":"Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection","volume":"7","author":"SANTOS J","year":"2000","unstructured":"SANTOS J, RIVERO A, MARQUEZ M: Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection. Ann. Med. Intern. (2000) 7:562\u2013563.","journal-title":"Ann. Med. Intern."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2000.00555.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(01)90110-5"},{"key":"e_1_2_1_22_1","first-page":"388","article-title":"FLAHERTY D, HEUVELMANS H et al","volume":"79","author":"MOORE E O&apos","year":"2001","unstructured":"MOORE E, O'FLAHERTY D, HEUVELMANS H et al.: Comparison of generic and propiarity sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya. Bull. World Health Organ. (2001) 79:388\u2013393.","journal-title":"Comparison of generic and propiarity sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya. Bull. World Health Organ."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1998.59.139"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2000000700016"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92952-C"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90037-8"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(00)90277-3"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91708-3"},{"key":"e_1_2_1_29_1","first-page":"938","volume":"22","author":"DAVIDSON RN","year":"1996","unstructured":"DAVIDSON RN, DI MARTINO L, GRAD ONI L et al.: Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (ambisome). Clin. Infect. Dis. (1996) 22:938\u2013943.","journal-title":"ONI L et al.: Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (ambisome). Clin. Infect. Dis."},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90557-X"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.3.762"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.8.2185-2197.2001"},{"key":"e_1_2_1_33_1","unstructured":"\u2022\u2022Excellent review on the treatment of VL. Numerous references particularly on immunological aspects."},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-2-199707150-00007"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(96)90271-0"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-199612000-00016"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10178-2"},{"key":"e_1_2_1_38_1","unstructured":"\u2022An extensive review on all clinical and therapeutic patterns of leishmaniases."},{"key":"e_1_2_1_39_1","first-page":"133","volume":"32","author":"RUSSO R","year":"1996","unstructured":"RUSSO R, NIGRO LC, MINNITI Set al.: Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (Ambisome). Infect. (1996) 32:133\u2013137.","journal-title":"MINNITI Set al.: Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (Ambisome). Infect."},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.4.625"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1086\/514784"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7310.419"},{"key":"e_1_2_1_43_1","unstructured":"\u2022Interesting paper on the modern management of VL."},{"key":"e_1_2_1_44_1","unstructured":"DAS VN RANJAN A SINHA AN et al.: A randomized clinical trial of low dosage combination of pentamidine and allo-purinol in the treatment of antimony un-responsive cases of visceral leishmaniasis. .1 Assoc. Physicians India (2001) 49:609\u2013613."},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.3.715"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(00)90130-5"},{"key":"e_1_2_1_47_1","first-page":"432","article-title":"PANDEY AK, SINHA GP MESSICK C, OLLIARO P: Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine)","volume":"94","author":"THAKUR CP","year":"2000","unstructured":"THAKUR CP, KANYOK TP, PANDEY AK, SINHA GP MESSICK C, OLLIARO P: Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. Trans. R. Soc. Bop. Med. Hyg. (2000) 94:432\u2013433.","journal-title":"An open-label randomized phase-II clinical study. Trans. R. Soc. Bop. Med. Hyg."},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(81)90198-X"},{"key":"e_1_2_1_49_1","first-page":"715","article-title":"Visceral leishmaniasis unresponsive to antimonial drugs","volume":"79","author":"CHUNGE CN","year":"1985","unstructured":"CHUNGE CN, GACHIHI G, MUIGAI R: Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Trans. R. Soc. Bop. Med. Hyg. (1985) 79:715\u2013718.","journal-title":"III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Trans. R. Soc. Bop. Med. Hyg."},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(83)90071-8"},{"key":"e_1_2_1_51_1","first-page":"611","article-title":"Treatment of visceral leishmaniasis with meglumine and allopurinol","volume":"147","author":"RAGUSA R","year":"1993","unstructured":"RAGUSA R, DI CATALDO A, SAMPERI P, SCHILIRO G: Treatment of visceral leishmaniasis with meglumine and allopurinol. Am.' Dis. Child. (1993) 147:611\u2013612.","journal-title":"Am.' Dis. Child."},{"key":"e_1_2_1_52_1","first-page":"319","article-title":"SINGH IJ, JHA S:Combination therapy in Kala-azar","volume":"43","author":"SINGH NK","year":"1995","unstructured":"SINGH NK, JHA TK, SINGH IJ, JHA S:Combination therapy in Kala-azar.J. Assoc. Physicians India (1995) 43:319\u2013320.","journal-title":"J. Assoc. Physicians India"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1999.tb01455.x"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4017(01)00399-5"},{"key":"e_1_2_1_55_1","first-page":"2633","article-title":"The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani Biochem","volume":"36","author":"CROFT SL","year":"1987","unstructured":"CROFT SL, NEAL RA, PENDERGAST W, CHAN JH: The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani Biochem. Pharmacol (1987) 36:2633\u20132636.","journal-title":"Pharmacol"},{"issue":"36","key":"e_1_2_1_56_1","first-page":"1630\u2013","article-title":"Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice","volume":"1992","author":"KUHLENCORD A","year":"1634","unstructured":"KUHLENCORD A, MANIERA T, EIBL H, UNGER C: Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrob. Agents Chemother: (1992) 36:1630\u20131634.","journal-title":"Antimicrob. Agents Chemother"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.3.654"},{"key":"e_1_2_1_58_1","first-page":"1041","article-title":"The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosome cruzi and Bypanosoma brucei Antimicrob","volume":"38","author":"CROFT SL","year":"1996","unstructured":"CROFT SL, SNOWDON D, YARDLEY V: The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosome cruzi and Bypanosoma brucei Antimicrob. Chemother. (1996) 38:1041\u20131047.","journal-title":"Chemother."},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1086\/315268"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182097001194"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.1.288-293.2000"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.11.3235-3236.2000"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04367-0"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1999.11813462"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912093412403"},{"key":"e_1_2_1_66_1","unstructured":"\u2022Excellent paper providing opening for future therapy of visceral leishmaniasis."},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1086\/318122"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/24.4.684"},{"key":"e_1_2_1_69_1","first-page":"2057","article-title":"Donn\u00e9es r\u00e9centes sur le traitement de la leishmaniose visc\u00e9rale","volume":"28","author":"GANGNEUX JP","year":"1999","unstructured":"GANGNEUX JP: Donn\u00e9es r\u00e9centes sur le traitement de la leishmaniose visc\u00e9rale. Presse Med. (1999) 28:2057\u20132066.","journal-title":"Presse Med."},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1201-9712(00)90078-X"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.6.1034"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.65.685"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.3.622"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.6.1627"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001043220104"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1086\/516526"},{"key":"e_1_2_1_77_1","first-page":"191","article-title":"Treatment of mediterranean visceral leishmaniasis","volume":"73","author":"GRADONI L","year":"1995","unstructured":"GRADONI L, BRYCESON A, DESJEUX P: Treatment of mediterranean visceral leishmaniasis. Bull. World Health Organ. (1995) 73:191\u2013197.","journal-title":"Bull. World Health Organ."},{"key":"e_1_2_1_78_1","first-page":"376","volume":"8","author":"Conclusions and recommendations of theIVth WHO joint meeting on Leishmania-HIV co-infections.","year":"2001","unstructured":"Conclusions and recommendations of theIVth WHO joint meeting on Leishmania-HIV co-infections. Parasite (2001) 8:376\u2013379.","journal-title":"Parasite"},{"key":"e_1_2_1_79_1","first-page":"1063","article-title":"Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B","volume":"13","author":"LAGUNA F","year":"1999","unstructured":"LAGUNA F, LOPEZ-VELEZ R, PULIDO F et al.: Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group. AIDS (1999) 13:1063\u20131069.","journal-title":"Spanish HIV-Leishmania Study Group. AIDS"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200003100-00011"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200012220-00020"},{"key":"e_1_2_1_82_1","first-page":"25","article-title":"Efficacy and safety of liposomal amphotericin B (Ambisome) for visceral leishmaniasis in endemic developing countries","volume":"76","author":"BERMAN JD","year":"1998","unstructured":"BERMAN JD, BADARO R, THAKUR CP et al.: Efficacy and safety of liposomal amphotericin B (Ambisome) for visceral leishmaniasis in endemic developing countries. Bull. World Health Organ. (1998) 76:25\u201332.","journal-title":"Bull. World Health Organ."},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2001.00778.x"},{"key":"e_1_2_1_84_1","first-page":"296","article-title":"BELKAID M, TABET-DERRAZ O: La leishmaniose visc\u00e9rale en Alg\u00e9rie","volume":"85","author":"HARRAT Z","year":"1992","unstructured":"HARRAT Z, ADDADI K, BELKAID M, TABET-DERRAZ O: La leishmaniose visc\u00e9rale en Alg\u00e9rie. Recensement des cas de leishmaniose visc\u00e9rale. Buff Soc. Path. Ex. (1992) 85:296\u2013301.","journal-title":"Recensement des cas de leishmaniose visc\u00e9rale. Buff Soc. Path. Ex."},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(94)90485-5"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.10.2.298"},{"key":"e_1_2_1_87_1","unstructured":"\u2022The key paper on LeishmanialHIV coinfection."},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199816000-00009"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(84)90131-7"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.3.8.1101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:52:11Z","timestamp":1768920731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.3.8.1101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":87,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["10.1517\/14656566.3.8.1101"],"URL":"https:\/\/doi.org\/10.1517\/14656566.3.8.1101","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}